NATURE’S SUNSHINE PRODUCTS, INC. Current Portion of Long-Term Debt
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Current Portion of Long-Term Debt of $0 as of 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2024-03-12
- 2023-12-31: Long-term Debt, Current Maturities $0.00.
- 2022-12-31: Long-term Debt, Current Maturities $1.17M.
- 2021-12-31: Long-term Debt, Current Maturities $1.24M.
- 2020-12-31: Long-term Debt, Current Maturities $1.31M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-12 |
| 2022-12-31 | $1.17M 10-K · filed 2024-03-12 |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-16 |
| 2020-12-31 | $1.31M 10-K · filed 2022-03-08 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-10 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2016-12-31 | $9.92M 10-K · filed 2018-03-16 |
| 2015-12-31 | $2.70M 10-K · filed 2017-03-14 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $572.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.42M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $2.27M 10-K · filed 2015-03-13 |
| 2013-09-30 | $3.11M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $3.37M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $3.36M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.35M 10-K · filed 2014-03-17 |
| 2012-09-30 | $3.33M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $3.32M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $3.31M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $3.30M 10-K · filed 2013-03-07 |
| 2011-09-30 | $3.28M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |